646 related articles for article (PubMed ID: 34012040)
1. COVID-19 non-pharmaceutical intervention portfolio effectiveness and risk communication predominance.
Chan LYH; Yuan B; Convertino M
Sci Rep; 2021 May; 11(1):10605. PubMed ID: 34012040
[TBL] [Abstract][Full Text] [Related]
2. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories.
Liu Y; Morgenstern C; Kelly J; Lowe R; ; Jit M
BMC Med; 2021 Feb; 19(1):40. PubMed ID: 33541353
[TBL] [Abstract][Full Text] [Related]
3. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H;
Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915
[TBL] [Abstract][Full Text] [Related]
4. Non Pharmaceutical Interventions for Optimal Control of COVID-19.
Zamir M; Shah Z; Nadeem F; Memood A; Alrabaiah H; Kumam P
Comput Methods Programs Biomed; 2020 Nov; 196():105642. PubMed ID: 32688137
[TBL] [Abstract][Full Text] [Related]
5. Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study comparing 16 worldwide countries.
Chowdhury R; Heng K; Shawon MSR; Goh G; Okonofua D; Ochoa-Rosales C; Gonzalez-Jaramillo V; Bhuiya A; Reidpath D; Prathapan S; Shahzad S; Althaus CL; Gonzalez-Jaramillo N; Franco OH;
Eur J Epidemiol; 2020 May; 35(5):389-399. PubMed ID: 32430840
[TBL] [Abstract][Full Text] [Related]
6. Epidemic Landscape and Forecasting of SARS-CoV-2 in India.
Rajendrakumar AL; Nair ATN; Nangia C; Chourasia PK; Chourasia MK; Syed MG; Nair AS; Nair AB; Koya MSF
J Epidemiol Glob Health; 2021 Mar; 11(1):55-59. PubMed ID: 32959618
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the impacts of non-pharmaceutical interventions on the transmission dynamics of COVID-19 in Canada based on mobile network.
Xue L; Jing S; Wang H
PLoS One; 2021; 16(12):e0261424. PubMed ID: 34965272
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated with the Implementation of Non-Pharmaceutical Interventions for Reducing Coronavirus Disease 2019 (COVID-19): A Systematic Review.
Regmi K; Lwin CM
Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920613
[TBL] [Abstract][Full Text] [Related]
9. Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland.
Lemaitre JC; Perez-Saez J; Azman AS; Rinaldo A; Fellay J
Swiss Med Wkly; 2020 May; 150():w20295. PubMed ID: 32472939
[TBL] [Abstract][Full Text] [Related]
10. Estimating the Effectiveness of Non-Pharmaceutical Interventions on COVID-19 Control in Korea.
Min KD; Kang H; Lee JY; Jeon S; Cho SI
J Korean Med Sci; 2020 Sep; 35(35):e321. PubMed ID: 32893522
[TBL] [Abstract][Full Text] [Related]
11. Accessing the syndemic of COVID-19 and malaria intervention in Africa.
Shi B; Zheng J; Xia S; Lin S; Wang X; Liu Y; Zhou XN; Liu J
Infect Dis Poverty; 2021 Jan; 10(1):5. PubMed ID: 33413680
[TBL] [Abstract][Full Text] [Related]
12. Development of the reproduction number from coronavirus SARS-CoV-2 case data in Germany and implications for political measures.
Khailaie S; Mitra T; Bandyopadhyay A; Schips M; Mascheroni P; Vanella P; Lange B; Binder SC; Meyer-Hermann M
BMC Med; 2021 Jan; 19(1):32. PubMed ID: 33504336
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Estimating the effect of social inequalities on the mitigation of COVID-19 across communities in Santiago de Chile.
Gozzi N; Tizzoni M; Chinazzi M; Ferres L; Vespignani A; Perra N
Nat Commun; 2021 Apr; 12(1):2429. PubMed ID: 33893279
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Strict State Measures on the Epidemiologic Curve of COVID-19 Infection in the Context of a Developing Country: A Simulation from Jordan.
Kheirallah KA; Alsinglawi B; Alzoubi A; Saidan MN; Mubin O; Alorjani MS; Mzayek F
Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32911738
[TBL] [Abstract][Full Text] [Related]
16. Data-driven inference of the reproduction number for COVID-19 before and after interventions for 51 European countries.
Karnakov P; Arampatzis G; Kičić I; Wermelinger F; Wälchli D; Papadimitriou C; Koumoutsakos P
Swiss Med Wkly; 2020 Jul; 150():w20313. PubMed ID: 32677705
[TBL] [Abstract][Full Text] [Related]
17. A dynamic model of the Coronavirus Disease 2019 outbreak to analyze the effectiveness of control measures.
Yang S; Liu Y; Chen K; Li T; Huang Y; Chen X; Qi P; Xu Y; Yu F; Yang Y; Chen Y
Medicine (Baltimore); 2021 Feb; 100(5):e23925. PubMed ID: 33592845
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the effectiveness of measures to control the novel coronavirus disease 2019 in Jilin Province, China.
Zhao Q; Wang Y; Yang M; Li M; Zhao Z; Lu X; Shen B; Luan B; Zhao Y; Cao B; Yao L; Zhao B; Su Y; Chen T
BMC Infect Dis; 2021 Mar; 21(1):245. PubMed ID: 33676420
[TBL] [Abstract][Full Text] [Related]
19. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
[TBL] [Abstract][Full Text] [Related]
20. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
